Nifty

:

15746.45

Sensex

:

52578.76

-78.00 (-0.49%)
-316.65 (-0.60%)

Login

Nifty
Sensex

:
:

15746.45
52578.76

-78.00 (-0.49%)
-316.65 (-0.60%)

FDC Ltd.

Pharmaceuticals & Drugs - Domestic

Rating :

55/99

BSE: 531599 | NSE: FDC

Watchlist

NSE BSE

376.10

26-Jul-2021

Open
High
Low
Previous Close

381.50
384.70
375.30
379.35

Volume
Traded Value (lacs)
52 Week High
52 Week Low

128006
487.16
404.90
255.20

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

6,346.42
21.06
1

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

6,319.89
0.21%
3.66

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

6.57
6.22
7.73

EBITDA CAGR (%)

10 Years
5 Years
3 Years

5.85
5.07
5.26

PAT CAGR (%)

10 Years
5 Years
3 Years

4.79
7.33
11.45

P:E (Median)

8 Years
5 Years
3 Years

19.74
19.71
18.67

P:BV (Average)

8 Years
5 Years
3 Years

3.03
2.98
2.77

EV:EBITDA (Average)

8 Years
5 Years
3 Years

12.26
12.83
12.18

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 21 Mar 20 Var% Dec 20 Dec 19 Var% Sep 20 Sep 19 Var% Jun 20 Jun 19 Var%
Net Sales 311.55 331.05 -5.89% 332.27 317.91 4.52% 375.54 345.17 8.80% 306.09 336.96 -9.16%
Expenses 274.21 304.19 -9.86% 263.34 235.20 11.96% 266.39 271.44 -1.86% 204.10 263.25 -22.47%
EBITDA 37.35 26.86 39.05% 68.93 82.71 -16.66% 109.14 73.72 48.05% 101.99 73.70 38.39%
EBIDTM 11.99% 8.11% 20.75% 26.02% 29.06% 21.36% 33.32% 21.87%
Other Income 22.10 42.45 -47.94% 35.23 31.82 10.72% 18.77 25.20 -25.52% 27.97 9.78 185.99%
Interest 1.05 0.99 6.06% 0.79 0.80 -1.25% 0.82 0.82 0.00% 0.75 0.81 -7.41%
Depreciation 9.48 9.30 1.94% 9.13 9.18 -0.54% 9.60 9.55 0.52% 9.41 9.34 0.75%
PBT 48.92 59.02 -17.11% 94.24 104.56 -9.87% 117.50 88.55 32.69% 119.79 73.34 63.34%
Tax 6.95 0.52 1,236.54% 23.46 31.23 -24.88% 26.38 25.87 1.97% 29.17 21.06 38.51%
PAT 41.96 58.49 -28.26% 70.78 73.33 -3.48% 91.12 62.68 45.37% 90.63 52.28 73.36%
PATM 13.47% 17.67% 21.30% 23.07% 24.26% 18.16% 29.61% 15.52%
EPS 2.49 3.47 -28.24% 4.19 4.34 -3.46% 5.40 3.71 45.55% 5.37 3.10 73.23%

Description Mar 21 Mar 20 Var% Dec 20 Dec 19 Var% Sep 20 Sep 19 Var% Jun 20 Jun 19 Var%
Net Sales 313.40 333.33 -5.98% 340.23 321.22 5.92% 371.39 346.12 7.30% 308.18 343.52 -10.29%
Expenses 261.79 304.04 -13.90% 266.50 236.49 12.69% 265.68 272.25 -2.41% 204.60 265.04 -22.80%
EBITDA 51.61 29.29 76.20% 73.73 84.73 -12.98% 105.72 73.87 43.12% 103.58 78.48 31.98%
EBIDTM 16.47% 8.79% 21.67% 26.38% 28.47% 21.34% 33.61% 22.84%
Other Income 14.97 37.76 -60.35% 35.05 31.03 12.96% 19.04 16.90 12.66% 27.97 9.79 185.70%
Interest 1.07 0.99 8.08% 0.80 0.79 1.27% 0.82 0.82 0.00% 0.75 0.81 -7.41%
Depreciation 9.54 9.32 2.36% 9.19 9.20 -0.11% 9.65 9.57 0.84% 9.44 9.36 0.85%
PBT 53.85 56.73 -5.08% 98.78 105.77 -6.61% 114.29 80.38 42.19% 121.36 78.09 55.41%
Tax 7.09 0.86 724.42% 23.57 31.51 -25.20% 26.43 25.97 1.77% 29.44 21.73 35.48%
PAT 46.76 55.88 -16.32% 75.21 74.25 1.29% 87.86 54.41 61.48% 91.92 56.36 63.09%
PATM 14.92% 16.76% 22.11% 23.12% 23.66% 15.72% 29.83% 16.41%
EPS 2.78 3.25 -14.46% 4.46 4.34 2.76% 5.15 3.16 62.97% 5.36 3.21 66.98%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description TTM Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Net Sales 1,325.45 1,331.09 1,075.87 1,062.20 1,008.91 986.81 877.65 837.02 764.60 699.24 700.36 Net Sales Growth -0.42% 23.72% 1.29% 5.28% 2.24% 12.44% 4.85% 9.47% 9.35% -0.16% Cost Of Goods Sold 412.05 424.53 344.49 349.98 338.09 355.07 266.17 261.14 252.75 231.59 247.61 Gross Profit 913.40 906.56 731.39 712.22 670.81 631.74 611.48 575.88 511.84 467.65 452.75 GP Margin 68.91% 68.11% 67.98% 67.05% 66.49% 64.02% 69.67% 68.80% 66.94% 66.88% 64.65% Total Expenditure 1,008.04 1,047.51 855.83 843.10 766.96 759.85 680.92 633.28 582.11 538.41 537.01 Power & Fuel Cost - 27.38 24.60 21.98 21.52 23.12 20.15 18.42 16.83 13.75 12.68 % Of Sales - 2.06% 2.29% 2.07% 2.13% 2.34% 2.30% 2.20% 2.20% 1.97% 1.81% Employee Cost - 276.18 226.19 215.47 189.93 174.53 136.24 120.74 106.43 98.27 84.91 % Of Sales - 20.75% 21.02% 20.29% 18.83% 17.69% 15.52% 14.42% 13.92% 14.05% 12.12% Manufacturing Exp. - 61.09 62.19 58.70 49.34 36.39 97.19 88.58 74.64 70.17 67.02 % Of Sales - 4.59% 5.78% 5.53% 4.89% 3.69% 11.07% 10.58% 9.76% 10.04% 9.57% General & Admin Exp. - 57.18 58.56 60.53 52.70 49.55 41.11 35.66 34.08 33.55 31.52 % Of Sales - 4.30% 5.44% 5.70% 5.22% 5.02% 4.68% 4.26% 4.46% 4.80% 4.50% Selling & Distn. Exp. - 94.70 78.94 75.96 64.36 57.73 64.96 58.43 56.15 55.44 55.12 % Of Sales - 7.11% 7.34% 7.15% 6.38% 5.85% 7.40% 6.98% 7.34% 7.93% 7.87% Miscellaneous Exp. - 106.45 60.87 60.47 50.99 63.47 55.10 50.31 41.23 35.64 55.12 % Of Sales - 8.00% 5.66% 5.69% 5.05% 6.43% 6.28% 6.01% 5.39% 5.10% 5.45% EBITDA 317.41 283.58 220.04 219.10 241.95 226.96 196.73 203.74 182.49 160.83 163.35 EBITDA Margin 23.95% 21.30% 20.45% 20.63% 23.98% 23.00% 22.42% 24.34% 23.87% 23.00% 23.32% Other Income 104.07 82.66 54.80 51.25 49.65 39.98 44.38 40.81 47.60 28.72 27.84 Interest 3.41 3.41 1.43 1.40 1.41 1.40 1.75 3.01 1.51 1.32 1.34 Depreciation 37.62 37.36 33.14 35.04 34.52 33.61 38.50 24.54 27.51 18.05 16.99 PBT 380.45 325.46 240.27 233.91 255.67 231.94 200.85 216.99 201.06 170.18 172.87 Tax 85.96 78.68 64.76 65.59 62.72 63.03 54.94 82.57 42.72 37.49 24.12 Tax Rate 22.59% 24.18% 27.41% 28.04% 25.11% 27.18% 27.35% 38.05% 21.25% 22.03% 13.95% PAT 294.49 246.78 171.54 168.31 187.07 168.90 145.91 134.42 158.33 132.69 148.75 PAT before Minority Interest 294.49 246.78 171.54 168.31 187.07 168.90 145.91 134.42 158.33 132.69 148.75 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 22.22% 18.54% 15.94% 15.85% 18.54% 17.12% 16.63% 16.06% 20.71% 18.98% 21.24% PAT Growth 19.33% 43.86% 1.92% -10.03% 10.76% 15.76% 8.55% -15.10% 19.32% -10.80% EPS 17.45 14.62 10.16 9.97 11.08 10.01 8.64 7.96 9.38 7.86 8.81

Description TTM Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Net Sales 1,333.20 1,344.19 1,090.70 1,075.07 1,013.87 994.32 889.31 845.85 772.83 710.54 711.67 Net Sales Growth -0.82% 23.24% 1.45% 6.04% 1.97% 11.81% 5.14% 9.45% 8.77% -0.16% Cost Of Goods Sold 413.49 425.72 345.14 352.08 339.05 357.93 272.91 266.16 311.11 237.54 253.93 Gross Profit 919.71 918.46 745.56 722.99 674.81 636.38 616.40 579.69 461.71 473.00 457.75 GP Margin 68.99% 68.33% 68.36% 67.25% 66.56% 64.00% 69.31% 68.53% 59.74% 66.57% 64.32% Total Expenditure 998.57 1,051.25 859.68 848.38 770.40 765.58 690.76 641.47 591.97 547.15 545.76 Power & Fuel Cost - 27.40 24.61 22.00 21.55 23.14 20.18 18.45 16.85 13.77 12.73 % Of Sales - 2.04% 2.26% 2.05% 2.13% 2.33% 2.27% 2.18% 2.18% 1.94% 1.79% Employee Cost - 277.48 225.57 216.67 191.08 175.76 137.58 122.05 107.52 99.02 85.57 % Of Sales - 20.64% 20.68% 20.15% 18.85% 17.68% 15.47% 14.43% 13.91% 13.94% 12.02% Manufacturing Exp. - 61.14 62.25 58.77 49.40 36.44 97.27 88.65 22.88 70.20 67.06 % Of Sales - 4.55% 5.71% 5.47% 4.87% 3.66% 10.94% 10.48% 2.96% 9.88% 9.42% General & Admin Exp. - 58.06 59.45 61.55 53.35 49.97 41.43 35.99 34.32 33.79 31.76 % Of Sales - 4.32% 5.45% 5.73% 5.26% 5.03% 4.66% 4.25% 4.44% 4.76% 4.46% Selling & Distn. Exp. - 94.70 78.92 75.96 64.36 57.73 64.96 58.43 56.15 55.45 55.12 % Of Sales - 7.05% 7.24% 7.07% 6.35% 5.81% 7.30% 6.91% 7.27% 7.80% 7.75% Miscellaneous Exp. - 106.74 63.73 61.35 51.61 64.61 56.43 51.73 43.13 37.36 55.12 % Of Sales - 7.94% 5.84% 5.71% 5.09% 6.50% 6.35% 6.12% 5.58% 5.26% 5.56% EBITDA 334.64 292.94 231.02 226.69 243.47 228.74 198.55 204.38 180.86 163.39 165.91 EBITDA Margin 25.10% 21.79% 21.18% 21.09% 24.01% 23.00% 22.33% 24.16% 23.40% 23.00% 23.31% Other Income 97.03 68.90 43.47 50.96 50.22 39.00 45.72 42.00 46.36 28.65 28.25 Interest 3.44 3.42 1.44 1.40 1.41 1.40 1.81 3.10 1.60 1.41 1.44 Depreciation 37.82 37.46 33.24 35.14 34.62 33.73 38.81 24.91 27.90 18.43 17.36 PBT 388.28 320.97 239.80 241.11 257.65 232.62 203.65 218.36 197.72 172.20 175.37 Tax 86.53 80.08 66.85 67.12 63.30 63.48 55.51 83.04 42.55 38.11 24.48 Tax Rate 22.29% 24.95% 28.01% 27.84% 25.14% 27.29% 27.26% 38.03% 21.52% 22.13% 13.96% PAT 301.75 240.89 171.85 173.99 188.47 169.14 148.15 135.32 155.17 134.09 150.89 PAT before Minority Interest 301.89 240.89 171.85 173.99 188.47 169.14 148.15 135.32 155.17 134.09 150.89 Minority Interest 0.14 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 22.63% 17.92% 15.76% 16.18% 18.59% 17.01% 16.66% 16.00% 20.08% 18.87% 21.20% PAT Growth 25.26% 40.17% -1.23% -7.68% 11.43% 14.17% 9.48% -12.79% 15.72% -11.13% EPS 17.88 14.27 10.18 10.31 11.17 10.02 8.78 8.02 9.19 7.94 8.94

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Shareholder's Funds 1,541.82 1,433.04 1,262.40 1,263.72 1,076.53 929.59 840.49 779.71 688.04 612.13 Share Capital 17.10 17.52 17.52 17.86 17.86 17.86 17.86 18.16 18.37 18.54 Total Reserves 1,524.72 1,415.52 1,244.88 1,245.86 1,058.67 911.72 822.63 761.54 669.67 593.59 Non-Current Liabilities 314.62 229.17 211.41 216.67 19.93 24.24 31.17 31.27 29.85 29.04 Secured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Unsecured Loans 0.34 0.49 0.60 0.69 0.79 0.90 1.07 1.24 1.45 1.73 Long Term Provisions 295.78 213.96 194.12 198.60 0.50 0.56 0.00 0.00 0.00 2.20 Current Liabilities 562.37 494.21 476.08 387.41 162.11 185.73 192.61 151.15 135.33 120.27 Trade Payables 117.54 77.20 96.95 74.66 82.30 86.26 79.38 59.76 56.45 44.79 Other Current Liabilities 79.53 60.88 66.76 63.10 49.58 36.28 42.00 35.42 29.41 29.06 Short Term Borrowings 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Short Term Provisions 365.29 356.13 312.37 249.65 30.24 63.19 71.23 55.97 49.47 46.43 Total Liabilities 2,418.81 2,156.42 1,949.89 1,867.80 1,258.57 1,139.56 1,064.27 962.13 853.22 761.44 Net Block 669.77 678.47 669.75 674.50 670.89 381.37 272.13 276.55 280.02 271.78 Gross Block 840.73 813.68 772.29 742.10 704.26 613.76 454.57 437.17 414.16 389.17 Accumulated Depreciation 170.96 135.21 102.53 67.61 33.36 232.39 182.43 160.61 134.14 117.38 Non Current Assets 1,177.74 1,109.97 973.09 954.70 738.52 640.95 613.60 551.96 411.40 317.87 Capital Work in Progress 23.85 12.38 12.84 6.32 19.92 28.80 18.10 7.22 10.72 10.18 Non Current Investment 162.53 179.33 74.40 54.82 39.76 223.12 193.32 251.55 102.59 14.34 Long Term Loans & Adv. 320.83 239.08 215.28 218.46 7.70 6.76 128.71 15.13 17.41 19.42 Other Non Current Assets 0.75 0.71 0.81 0.60 0.25 0.90 1.33 1.51 0.65 2.15 Current Assets 1,241.06 1,046.45 976.80 913.10 520.05 498.17 450.20 409.66 441.28 443.51 Current Investments 502.24 405.93 397.16 436.53 285.41 272.49 229.90 170.91 243.92 248.86 Inventories 209.49 172.73 159.65 136.22 130.24 121.53 100.59 97.45 101.03 95.85 Sundry Debtors 124.19 83.52 76.71 77.46 64.03 60.70 60.82 44.76 40.69 39.60 Cash & Bank 28.96 15.70 21.12 23.02 13.50 11.66 21.25 34.90 13.42 16.05 Other Current Assets 376.17 11.01 10.51 9.42 26.88 31.79 37.63 61.64 42.22 43.16 Short Term Loans & Adv. 349.81 357.56 311.65 230.44 20.30 16.15 29.55 50.28 36.21 40.86 Net Current Assets 678.69 552.24 500.72 525.69 357.93 312.44 257.59 258.51 305.95 323.24 Total Assets 2,418.80 2,156.42 1,949.89 1,867.80 1,258.57 1,139.55 1,064.27 962.12 853.22 761.44

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Shareholder's Funds 1,547.43 1,445.24 1,276.11 1,270.20 1,082.47 936.38 845.30 784.24 695.42 616.39 Share Capital 17.10 17.52 17.52 17.86 17.86 17.86 17.86 18.16 18.37 18.54 Total Reserves 1,530.33 1,427.72 1,258.59 1,252.34 1,064.61 918.52 827.43 766.08 677.05 597.86 Non-Current Liabilities 314.62 229.17 211.41 216.67 19.93 24.06 30.97 31.32 30.24 29.59 Secured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.22 0.56 0.77 Unsecured Loans 0.34 0.49 0.60 0.69 0.79 0.90 1.07 1.24 1.45 1.73 Long Term Provisions 295.78 213.96 194.12 198.60 0.50 0.56 0.00 0.00 0.00 2.20 Current Liabilities 564.62 497.43 480.07 389.40 163.42 187.97 195.69 153.97 139.01 123.45 Trade Payables 117.86 77.61 97.32 75.10 82.59 87.17 80.05 61.04 57.64 45.90 Other Current Liabilities 80.06 61.67 68.78 64.11 50.16 36.61 42.87 35.98 30.09 29.60 Short Term Borrowings 0.00 0.00 0.00 0.00 0.00 1.00 1.11 1.14 1.29 1.27 Short Term Provisions 366.69 358.15 313.97 250.19 30.67 63.19 71.66 55.81 49.99 46.68 Total Liabilities 2,426.67 2,171.84 1,967.59 1,876.27 1,265.82 1,148.41 1,071.96 969.53 864.67 769.43 Net Block 673.50 682.19 673.64 678.05 675.16 393.04 284.40 289.19 293.04 276.74 Gross Block 844.97 817.80 776.49 745.84 708.81 629.67 470.42 453.02 430.01 396.15 Accumulated Depreciation 171.47 135.61 102.84 67.79 33.65 236.62 186.02 163.82 136.96 119.41 Non Current Assets 1,181.25 1,113.46 976.64 957.93 742.46 646.27 619.47 558.20 418.02 322.50 Capital Work in Progress 23.85 12.38 12.84 6.32 19.92 28.80 18.10 7.22 10.72 10.18 Non Current Investment 162.31 179.11 74.07 54.49 39.43 216.72 186.92 245.15 96.20 14.01 Long Term Loans & Adv. 320.83 239.08 215.28 218.46 7.70 6.37 128.71 15.13 17.41 19.42 Other Non Current Assets 0.75 0.71 0.81 0.60 0.25 1.33 1.33 1.51 0.65 2.15 Current Assets 1,245.41 1,058.38 990.94 918.34 523.36 502.13 452.03 410.83 446.10 446.88 Current Investments 502.24 405.93 397.16 436.53 285.41 272.49 229.90 170.91 243.92 248.86 Inventories 209.96 173.79 160.49 137.16 130.91 123.22 103.00 99.71 102.92 97.42 Sundry Debtors 123.74 87.53 81.66 76.06 61.94 61.04 59.36 43.23 41.97 40.75 Cash & Bank 32.32 21.26 29.30 28.47 18.02 14.95 23.43 36.50 16.78 17.76 Other Current Assets 377.15 11.32 10.68 9.68 27.10 30.44 36.33 60.49 40.52 42.09 Short Term Loans & Adv. 350.34 358.56 311.65 230.44 20.36 14.77 28.18 48.89 34.66 39.71 Net Current Assets 680.79 560.94 510.87 528.94 359.94 314.16 256.33 256.86 307.09 323.43 Total Assets 2,426.66 2,171.84 1,967.58 1,876.27 1,265.82 1,148.40 1,071.97 969.53 864.66 769.44

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Cash From Operating Activity 239.04 103.79 147.76 153.09 171.09 126.56 148.82 149.05 142.53 118.68 PBT 325.46 240.27 233.91 255.67 231.94 200.85 216.99 201.06 170.18 172.87 Adjustment 8.36 -13.54 -1.86 -11.07 0.24 -1.54 -7.41 -16.65 -3.00 0.77 Changes in Working Capital -11.00 -51.34 -16.54 -18.76 -5.75 -10.77 7.39 1.86 9.22 -20.62 Cash after chg. in Working capital 322.82 175.38 215.50 225.84 226.42 188.54 216.98 186.26 176.40 153.02 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -83.78 -71.60 -67.75 -69.78 -55.33 -61.98 -68.16 -37.22 -33.87 -34.34 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 -2.97 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -84.80 -109.30 20.15 -143.55 -72.76 -88.89 -55.38 -105.08 -108.62 -30.36 Net Fixed Assets -38.52 -40.93 -36.71 -24.24 -81.62 -169.89 -28.28 -19.51 -25.53 -17.54 Net Investments -79.51 -113.70 19.79 -166.18 170.44 -72.39 -0.76 -75.95 -83.31 -33.71 Others 33.23 45.33 37.07 46.87 -161.58 153.39 -26.34 -9.62 0.22 20.89 Cash from Financing Activity -142.00 -0.07 -169.43 0.35 -96.98 -47.47 -74.93 -62.28 -57.66 -57.35 Net Cash Inflow / Outflow 12.24 -5.58 -1.53 9.90 1.36 -9.80 18.51 -18.30 -23.75 30.97 Opening Cash & Equivalents 14.36 19.94 21.66 11.74 10.58 21.08 2.57 20.87 44.62 13.65 Closing Cash & Equivalent 26.52 14.36 19.94 21.66 11.74 11.28 21.08 2.57 20.87 44.62

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Cash From Operating Activity 250.38 112.43 149.84 154.49 174.30 127.64 149.72 149.94 144.33 120.74 PBT 319.95 237.75 240.63 257.71 232.15 203.65 218.36 197.72 172.20 175.37 Adjustment 22.58 -0.21 0.39 -10.88 2.41 -1.40 -7.67 -14.20 -2.62 1.31 Changes in Working Capital -7.77 -51.05 -23.24 -19.23 -4.54 -11.78 7.09 4.14 9.01 -20.98 Cash after chg. in Working capital 334.77 186.49 217.78 227.60 230.02 190.48 217.79 187.66 178.59 155.70 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -84.39 -74.06 -67.94 -70.14 -55.73 -62.84 -68.07 -37.72 -34.26 -34.97 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 -2.97 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -98.35 -120.33 20.11 -143.55 -73.05 -88.57 -55.38 -107.18 -108.25 -33.00 Net Fixed Assets -38.52 -40.93 -36.71 -24.24 -81.62 -169.89 -28.28 -19.51 -25.53 -17.54 Net Investments -79.51 -113.70 19.79 -166.18 170.44 -72.39 -0.76 -75.95 -83.31 -33.71 Others 19.68 34.30 37.03 46.87 -161.87 153.71 -26.34 -11.72 0.59 18.25 Cash from Financing Activity -142.00 -0.07 -169.43 0.35 -96.98 -47.76 -75.25 -62.83 -58.18 -57.51 Net Cash Inflow / Outflow 10.03 -7.96 0.52 11.29 4.27 -8.69 19.09 -20.06 -22.10 30.22 Opening Cash & Equivalents 19.92 28.13 27.10 16.25 12.17 23.26 4.17 24.23 46.33 16.11 Closing Cash & Equivalent 29.88 19.92 28.13 27.10 16.25 14.56 23.26 4.17 24.23 46.33

Financial Ratios

Consolidated /

Standalone

Right to Left

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Book Value (Rs.) 90.18 82.16 72.38 71.06 60.53 52.22 47.20 43.05 37.54 33.12 ROA 10.79% 8.35% 8.82% 11.97% 14.09% 13.24% 13.27% 17.44% 16.44% 20.74% ROE 16.59% 12.73% 13.33% 15.99% 16.85% 16.50% 16.62% 21.61% 20.45% 26.22% ROCE 22.06% 17.63% 18.62% 21.45% 23.25% 22.89% 27.15% 27.59% 26.34% 30.58% Fixed Asset Turnover 1.65 1.39 1.41 1.45 1.53 1.68 1.91 1.83 1.77 1.92 Receivable days 27.76 26.53 26.29 24.69 22.54 24.73 22.57 19.99 20.59 19.27 Inventory Days 51.08 55.04 50.45 46.49 45.50 45.20 42.33 46.42 50.48 47.43 Payable days 38.45 40.20 41.31 40.79 44.71 48.03 44.04 40.19 37.05 32.64 Cash Conversion Cycle 40.39 41.37 35.43 30.39 23.32 21.90 20.86 26.22 34.02 34.06 Total Debt/Equity 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Interest Cover 96.31 166.02 167.77 178.52 167.05 115.57 73.00 134.11 129.58 130.03

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Book Value (Rs.) 90.51 82.86 73.17 71.42 60.87 52.62 47.47 43.30 37.95 33.35 ROA 10.48% 8.30% 9.05% 12.00% 14.01% 13.34% 13.26% 16.92% 16.41% 20.83% ROE 16.10% 12.63% 13.67% 16.02% 16.76% 16.64% 16.63% 21.01% 20.48% 26.44% ROCE 21.63% 17.64% 19.04% 21.51% 23.15% 23.02% 27.12% 26.85% 26.34% 30.73% Fixed Asset Turnover 1.66 1.41 1.42 1.44 1.52 1.65 1.87 1.79 1.75 1.91 Receivable days 27.96 27.55 26.58 23.96 22.06 24.19 21.70 19.72 20.88 19.59 Inventory Days 50.80 54.43 50.15 46.55 45.58 45.45 42.89 46.90 50.57 47.41 Payable days 38.50 40.35 41.32 40.83 44.81 47.89 44.12 40.39 37.33 32.94 Cash Conversion Cycle 40.26 41.62 35.41 29.68 22.84 21.74 20.47 26.23 34.12 34.06 Total Debt/Equity 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.01 Interest Cover 94.95 166.95 172.62 179.60 167.11 113.30 71.41 124.23 122.88 122.86

Top Investors:

nippon life india trustee ltd-a/c nippon india small cap fund

fidelity puritan trust-fidelity low-priced stock fund

bengal finance and investment pvt ltd

Annual Reports:

News Update:

FDC launches oral suspension of Favipiravir
12th Jul 2021, 16:43 PM

This prescription-only Favenza oral suspension is currently available at all retail medical outlets and hospital pharmacies across India
Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback